CH390260A - Process for the preparation of new carbostyril derivatives - Google Patents
Process for the preparation of new carbostyril derivativesInfo
- Publication number
- CH390260A CH390260A CH1554964A CH1554964A CH390260A CH 390260 A CH390260 A CH 390260A CH 1554964 A CH1554964 A CH 1554964A CH 1554964 A CH1554964 A CH 1554964A CH 390260 A CH390260 A CH 390260A
- Authority
- CH
- Switzerland
- Prior art keywords
- formula
- hydrogen
- group
- compound
- radical
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 5
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical class C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 title description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 11
- 239000001257 hydrogen Substances 0.000 claims description 11
- 150000002431 hydrogen Chemical class 0.000 claims description 7
- 125000005843 halogen group Chemical group 0.000 claims description 6
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- 125000001931 aliphatic group Chemical group 0.000 claims description 2
- 125000005277 alkyl imino group Chemical group 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 239000011230 binding agent Substances 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 claims description 2
- 229910052751 metal Inorganic materials 0.000 claims description 2
- 239000002184 metal Substances 0.000 claims description 2
- 150000007522 mineralic acids Chemical class 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- 150000001412 amines Chemical class 0.000 claims 1
- -1 hydrocarbon radical Chemical class 0.000 description 28
- 150000003254 radicals Chemical class 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- QQJCNAZVIHGLJF-UHFFFAOYSA-N 4-(dimethylamino)-1-methylquinolin-2-one Chemical compound CN(C)C1=CC(=O)N(C)C2=CC=CC=C12 QQJCNAZVIHGLJF-UHFFFAOYSA-N 0.000 description 2
- QMJIZKDMMDVBRJ-UHFFFAOYSA-N 4-(dimethylamino)-1H-quinolin-2-one Chemical compound OC1=NC2=CC=CC=C2C(=C1)N(C)C QMJIZKDMMDVBRJ-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- MPPPKRYCTPRNTB-UHFFFAOYSA-N 1-bromobutane Chemical compound CCCCBr MPPPKRYCTPRNTB-UHFFFAOYSA-N 0.000 description 1
- WPWHSFAFEBZWBB-UHFFFAOYSA-N 1-butyl radical Chemical group [CH2]CCC WPWHSFAFEBZWBB-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000002774 3,4-dimethoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C(OC([H])([H])[H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- USEGQJLHQSTGHW-UHFFFAOYSA-N 3-bromo-2-methylprop-1-ene Chemical compound CC(=C)CBr USEGQJLHQSTGHW-UHFFFAOYSA-N 0.000 description 1
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 1
- GCDMPAYXWPDYDQ-UHFFFAOYSA-N 4-amino-3-butyl-1-methylquinolin-2-one Chemical compound CCCCC1=C(N)C2=CC=CC=C2N(C)C1=O GCDMPAYXWPDYDQ-UHFFFAOYSA-N 0.000 description 1
- 125000006281 4-bromobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Br)C([H])([H])* 0.000 description 1
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 description 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- REHHBTUVMSHZNT-UHFFFAOYSA-N bromocyclohexatriene Chemical compound BrC1=CC=C=C[CH]1 REHHBTUVMSHZNT-UHFFFAOYSA-N 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- QSKWJTXWJJOJFP-UHFFFAOYSA-N chloroform;ethoxyethane Chemical compound ClC(Cl)Cl.CCOCC QSKWJTXWJJOJFP-UHFFFAOYSA-N 0.000 description 1
- HXCKCCRKGXHOBK-UHFFFAOYSA-N cycloheptane Chemical compound [CH]1CCCCCC1 HXCKCCRKGXHOBK-UHFFFAOYSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 1
- 229940008406 diethyl sulfate Drugs 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- DITHIFQMPPCBCU-UHFFFAOYSA-N propa-1,2-diene Chemical compound [CH]=C=C DITHIFQMPPCBCU-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 125000005853 β-dimethylaminoethyl group Chemical group 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Verfahren zur Herstellung von neuen Carbostyrilderivaten Die vorliegende Erfindung betrifft ein Verfahren zur Herstellung von neuen Carbostyrilderivaten, die insbesondere als Arzneimittel und Zwischenprodukte zur Herstellung solcher verwendbar sind.
Carbostyrilderivate der Formel
EMI0001.0006
worin R1 einen aliphatischen oder cycloaliphatischen Koh- lenwasserstoffrest bedeutet, welcher durch Sauer stoff unterbrochen und/oder an Doppelbindungen durch Halogenatome substituiert sein kann, R.., Wasserstoff oder dasselbe wie R1, insbesondere einen niederen Alkylrest, R@ Wasserstoff, ein Halogenatom, eine niedere Alkyl- oder Alkoxygruppe, die Nitrogruppe,
Cyanogruppe oder Trifluormethylgruppe, R4 Wasserstoff, ein Halogenatom oder eine niedere Alkyl- oder Alkoxygruppe, R5 Wasserstoff, dasselbe wie R1 oder eine niedere Dialkylaminoalkyl-, Polymethyleniminoalkyl- oder Morpholinoalkylgruppe, und R6 Wasserstoff oder einen niederen Alkylrest bedeutet, wobei Alkylreste R5 und R,
auch unter sich direkt oder über ein Sauerstoffatom oder eine niedere Alkyliminogruppe verbunden sein können, sind bisher nicht bekanntgeworden. Wie nun über raschenderweise gefunden wurde, besitzen diese Ver- bindungen und ihre Salze mit anorganischen oder organischen Säuren wertvolle pharmakologische Eigenschaften, insbesondere analgetische, antiphlo- gistische und antipyretische Wirksamkeit. Sie eignen sich z. B. zur Schmerzlinderung und zur Behandlung rheumatischer Krankheiten, wobei sie per os oder parenteral verabreicht werden.
In den Verbindungen der Formel I ist R1 beispielsweise durch einen Alkyl- rest, wie z. B. den Methyl-, Äthyl-, n-Propyl-, Isopropyl-, n-Amyl-, Isoamyl- oder n-Hexylrest, einen Alkenylrest, wie z.
B. den Allyl-, ss-Methallyl- oder Crotylrest, durch den Propargylrest, den P)-Methoxyäthylrest oder /3-Athoxyäthylrest, einen Cycloalkylrest, wie z. B. den Cyclopentyl-, Cyclohexyl- oder Cycloheptylrest, einen aromatischen Rest, wie z.
B. den Phenyl-, o-Tolyl-, m-Tolyl-, p-Tolyl-, p-Methoxy-phenyl-, p-Äthoxy-phenyl, m-Chlor-phenyl-, p-Chlor-phenyl-, p-Fluor-phenyl- oder p-Brom-phenylrest, oder einen araliphatischen Rest, wie z.
B. den Benzyl-, p-Methyl-benzyl-, o-Methyl-benzyl-, p-Methoxy-benzyl-, 3,4-Dimethoxy-benzyl-, p-Chlor-benzyl-, p-Brom benzyl-, P-Phenyl-äthyl oder y-Phenyl-propylrest verkörpert. R, kann beispielsweise Wasserstoff, einen der bei R1 genannten Reste sowie z.
B. den Tertiär- butylrest, 2,5 -Endomethylen-1-cyclohexenyl- (1)- methylrest oder Tetrahydrofurfurylrest bedeuten. Als Ringsubstituenten R3 und R4 kommen z. B.
Chlor-, Brom- oder Fluoratome, Methyl-, Äthyl- und Iso- propylreste, Methoxy-, Äthoxy-, n-Propoxy-, Iso- propoxy- und n-Butoxyreste sowie für R3 die in der Definition spezifisch genannten Reste in Betracht. Vertreter von Resten, die für R, in Frage kommen, sind neben Wasserstoff z.
B. die als Beispiele für R1 genannten Reste sowie die ssDimethylamino-äthyl-, ss-Diäthylamino-äthyl-, p,-(Di-n-butyl-amino)-äthyl-, ss-Dimethylamino-propyl-, y-Dimethylamino-propyl-, y-Diäthylamino-propyl-, y-Dimethylamino-butyl-, y-Dimethylamino-P)-methyl-propyl-, b-Dimethylamino-butyl-, b-Diäthylamino-butyl-, ss-Piperidino-äthyl-, ss-Morpholino-äthyl-,
fi-Piperidino-propyl-, y-Pyrrolidyl-(1) propyl-, y-Piperidino propyl-, y-Morpholino-propyl- oder b-Piperidino-butylgruppe; und Vertreter von R., z. B. Wasserstoff und der Methyl-, Äthyl-, n-Propyl- und n-Butylrest.
R5 und R6 können zusammen mit dem anlie genden Stickstoffatom im weiteren z. B. den Athylenimino-, Pyrrolidyl-(1)-, Piperidino-, Hexamethylenimino-, Heptamethylenimino-, Morpholino-, 4-Methyl-piperazinyl-(1)-, 4-Athyl-piperazinyl-(1)- oder 4-Isopropyl-piperazinyl-(1)-rest bedeuten.
Zur Herstellung von Verbindungen der Formel 1 setzt man Verbindungen der Formel
EMI0002.0037
in Gegenwart eines säurebindenden Mittels oder nach Überführung in Salze einwertiger Metalle mit reak tionsfähigen Estern von Verbindungen der Formel Rj- OH III um.
Zur Durchführung der Umsetzung löst man die Verbindung der Formel 1I beispielsweise in methano- lischer oder äthanolischer Kalilauge oder Natron lauge, fügt allmählich den benötigten reaktions fähigen Ester, wie z.
B. Methyljodid, Athyljodid, n - Butylbromid, Allylbromid, Methallylbromid, Benzylchlorid, Dimethylsulfat oder Diäthylsulfat zu und erwärmt das Gemisch, z. B. zum Kochen unter Rückfluss oder auf höhere Temperaturen im ge schlossenen System. Einige Ausgangsstoffe der For mel II sind bekannt und weitere in an sich bekann ter Weise, z.
B. durch Erhitzen von gegebenenfalls substituiertem 2,4-Dioxy-chinolin mit geeigneten Monoaminen oder Diaminen, herstellbar.
In den nachfolgenden Beispielen bedeuten Teile Gewichtsteile. Diese verhalten sich zu Volumteilen wie g zu cm3. Die Temperaturen sind in Celsius graden angegeben.
<I>Beispiel 1</I> 8 6 Teile 2 - Hydroxy - 3 - butyl-4-amino-chinolin werden in 1000 Teilen 41/2%iger methanolischer Kalilauge gelöst. Dann werden 260 Teile Methyljodid unter Rühren zugesetzt und das Gemisch 3 Stunden unter Rückfluss gekocht.
Hierauf befreit man vom Lösungsmittel und chromatographiert den Rückstand an einer Säule von neutralem Aluminiumoxyd. Die mit Chloroform eluierten Fraktionen enthalten das 1- Methyl- 3 - butyl-4-amino-carbostyril. Aus Äther kristallisiert es in Nadeln vom Smp. 105-106 .
Unter Verwendung der geeigneten Ausgangs stoffe erhält man nach dem im obigen Beispiel be schriebenen Verfahren 1-Methyl-4-dimethylamino- carbostyril vom Smp. 56-58 (aus Äther) und 1-y Dimethylaminopropylamino-4-dimethylamino-carbo- styril. Das Hydrochlorid der letztgenannten Verbin dung schmilzt bei 204-205 .
<I>Beispiel 2</I> Zu einer gerührten Mischung von 1,3 Teilen 2 - Hydroxy - 4 - dimethylamino - chinolin und 1,06 Teilen Soda in 40 Volumteilen Dimethylformamid gibt man tropfenweise 1,5 Teile Methyljodid zu. Die Suspension wird 3 Stunden bei 25 und 2 Stun den bei 45' gerührt und anschliessend auf 200 Vo- lumteile Eiswasser gegossen.
Man saugt es vom aus geschiedenen unveränderten 2-Hydroxy-4-dimethyl- amino-chinolin und engt das Filtrat am Vakuum zur Trockne ein. Der Rückstand, ein gelbes Öl, wird an neutralem Aluminiumoxyd chromatographiert. Die mit Chloroform-Äther (1 :8) eluierten Fraktionen enthalten das 1-Methyl-4-dimethylamino-carbostyril. Es kristallisiert aus Äther mit dem Schmelzpunkt von 58 .
Process for the Production of New Carbostyril Derivatives The present invention relates to a process for the production of new carbostyril derivatives, which can be used in particular as medicaments and intermediates for the production thereof.
Carbostyril derivatives of the formula
EMI0001.0006
where R1 is an aliphatic or cycloaliphatic hydrocarbon radical which can be interrupted by oxygen and / or substituted on double bonds by halogen atoms, R .., hydrogen or the same as R1, in particular a lower alkyl radical, R @ hydrogen, a halogen atom, a lower alkyl or alkoxy group, the nitro group,
Cyano group or trifluoromethyl group, R4 is hydrogen, a halogen atom or a lower alkyl or alkoxy group, R5 is hydrogen, the same as R1 or a lower dialkylaminoalkyl, polymethyleneiminoalkyl or morpholinoalkyl group, and R6 is hydrogen or a lower alkyl radical, where alkyl radicals R5 and R,
can also be linked directly or via an oxygen atom or a lower alkylimino group have not yet become known. As has now surprisingly been found, these compounds and their salts with inorganic or organic acids have valuable pharmacological properties, in particular analgesic, anti-inflammatory and anti-pyretic activity. They are suitable e.g. B. for pain relief and for the treatment of rheumatic diseases, where they are administered orally or parenterally.
In the compounds of formula I, R1 is, for example, by an alkyl radical, such as. B. the methyl, ethyl, n-propyl, isopropyl, n-amyl, isoamyl or n-hexyl radical, an alkenyl radical, such as.
B. the allyl, ss-methallyl or crotyl radical, through the propargyl radical, the P) methoxyethyl radical or / 3-ethoxyethyl radical, a cycloalkyl radical, such as. B. the cyclopentyl, cyclohexyl or cycloheptyl radical, an aromatic radical, such as.
B. the phenyl, o-tolyl, m-tolyl, p-tolyl, p-methoxyphenyl, p-ethoxyphenyl, m-chlorophenyl, p-chlorophenyl, p- Fluorophenyl or p-bromo-phenyl radical, or an araliphatic radical, such as.
B. benzyl, p-methyl-benzyl, o-methyl-benzyl, p-methoxy-benzyl, 3,4-dimethoxy-benzyl, p-chloro-benzyl, p-bromobenzyl, P -Phenyl-ethyl or y-phenyl-propyl radical embodied. R can, for example, hydrogen, one of the radicals mentioned for R1 and, for.
B. the tertiary butyl radical, 2,5-endomethylene-1-cyclohexenyl- (1) - methyl radical or tetrahydrofurfuryl radical. As ring substituents R3 and R4, for. B.
Chlorine, bromine or fluorine atoms, methyl, ethyl and isopropyl radicals, methoxy, ethoxy, n-propoxy, isopropoxy and n-butoxy radicals and, for R3, the radicals specifically mentioned in the definition. Representatives of radicals that come into question for R are, in addition to hydrogen, for.
B. the radicals mentioned as examples for R1 and the ss-dimethylamino-ethyl, ss-diethylamino-ethyl, p, - (di-n-butyl-amino) -ethyl, ss-dimethylamino-propyl, y-dimethylamino propyl-, y-diethylamino-propyl-, y-dimethylamino-butyl-, y-dimethylamino-P) -methyl-propyl-, b-dimethylamino-butyl-, b-diethylamino-butyl-, ss-piperidino-ethyl-, ss-morpholino-ethyl-,
fi-piperidino-propyl, γ-pyrrolidyl- (1) propyl, γ-piperidino propyl, γ-morpholino-propyl or b-piperidino-butyl group; and representatives of R., e.g. B. hydrogen and the methyl, ethyl, n-propyl and n-butyl radicals.
R5 and R6 can together with the anlie ing nitrogen atom in the further z. B. the ethyleneimino-, pyrrolidyl- (1) -, piperidino-, hexamethyleneimino-, heptamethyleneimino-, morpholino-, 4-methyl-piperazinyl- (1) -, 4-ethyl-piperazinyl- (1) - or 4-isopropyl -piperazinyl- (1) radical.
To prepare compounds of the formula 1, compounds of the formula are used
EMI0002.0037
in the presence of an acid-binding agent or after conversion into salts of monovalent metals with reactive esters of compounds of the formula Rj-OH III.
To carry out the reaction, the compound of formula 1I is dissolved, for example, in methanolic or ethanolic potassium hydroxide or sodium hydroxide solution, and the required reactive ester, such as.
B. methyl iodide, ethyl iodide, n - butyl bromide, allyl bromide, methallyl bromide, benzyl chloride, dimethyl sulfate or diethyl sulfate and the mixture is heated, e.g. B. for boiling under reflux or at higher temperatures in the ge closed system. Some starting materials of the For mel II are known and others in a well-known manner, for.
B. by heating optionally substituted 2,4-dioxyquinoline with suitable monoamines or diamines, can be prepared.
In the following examples, parts mean parts by weight. These are related to parts of volume as g to cm3. The temperatures are given in degrees Celsius.
<I> Example 1 </I> 8 6 parts of 2 - hydroxy - 3 - butyl-4-aminoquinoline are dissolved in 1000 parts of 41/2% strength methanolic potassium hydroxide solution. Then 260 parts of methyl iodide are added with stirring and the mixture is refluxed for 3 hours.
The solvent is then removed and the residue is chromatographed on a column of neutral aluminum oxide. The fractions eluted with chloroform contain 1-methyl-3-butyl-4-aminocarbostyril. It crystallizes from ether in needles with a melting point of 105-106.
Using the appropriate starting materials, 1-methyl-4-dimethylamino-carbostyril with a melting point of 56-58 (from ether) and 1-y-dimethylaminopropylamino-4-dimethylamino-carbo-styril are obtained by the process described in the above example. The hydrochloride of the latter compound melts at 204-205.
<I> Example 2 </I> 1.5 parts of methyl iodide are added dropwise to a stirred mixture of 1.3 parts of 2-hydroxy-4-dimethylamino-quinoline and 1.06 parts of soda in 40 parts by volume of dimethylformamide. The suspension is stirred for 3 hours at 25 and 2 hours at 45 'and then poured onto 200 parts by volume of ice water.
The unchanged 2-hydroxy-4-dimethylamino-quinoline which has separated out is sucked off and the filtrate is concentrated to dryness in a vacuum. The residue, a yellow oil, is chromatographed on neutral aluminum oxide. The fractions eluted with chloroform-ether (1: 8) contain 1-methyl-4-dimethylamino-carbostyril. It crystallizes from ether with a melting point of 58.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1554964A CH390260A (en) | 1960-08-10 | 1960-08-10 | Process for the preparation of new carbostyril derivatives |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1554964A CH390260A (en) | 1960-08-10 | 1960-08-10 | Process for the preparation of new carbostyril derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH390260A true CH390260A (en) | 1965-04-15 |
Family
ID=4410001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1554964A CH390260A (en) | 1960-08-10 | 1960-08-10 | Process for the preparation of new carbostyril derivatives |
Country Status (1)
| Country | Link |
|---|---|
| CH (1) | CH390260A (en) |
-
1960
- 1960-08-10 CH CH1554964A patent/CH390260A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH616923A5 (en) | ||
| EP0007019A1 (en) | 5-Phenyl-pyrazole derivatives and their salts, processes for their preparation and medicines containing them | |
| DE2555789A1 (en) | Antiinflammatory and analgesic hydroxy-methylene-cyano-acetanilides - prepd. e.g. by reacting cyanoacetanilide derivs. with ortho-esters and hydrolysing | |
| CH506525A (en) | Aromatic ethers | |
| DE2514914C2 (en) | Phenethylaminoketone derivatives, their manufacture and pharmaceutical preparations based on them | |
| CH637646A5 (en) | ANALGETICALLY ACTIVE TRIAZINDIONE, PRODUCTION PROCESS AND PHARMACEUTICAL COMPOSITIONS. | |
| DE894396C (en) | Process for the preparation of 1- (o-, m- or p-oxyphenyl) -1-oxy-2-aralkylamino-ethanes | |
| CH638525A5 (en) | 3- (TETRAZOL-5-YL) -1-AZAXANTHONE AND METHOD FOR THE PRODUCTION THEREOF. | |
| DE2156501A1 (en) | 5,6-benzo-gamma-pyridone derivs - inters for anticarcinogenic cpds | |
| AT235842B (en) | Process for the preparation of new carbostyril derivatives | |
| DE936747C (en) | Process for the production of new pyrimidine derivatives and their salts | |
| DE1804328A1 (en) | 3-substituted quinoxalinones and process for their | |
| DE2012943A1 (en) | Novel triazole derivatives and processes for making the same | |
| DE1695903A1 (en) | Process for the preparation of new 5,11-dihydro-6H-pyrido [2,3-b] [1,4] substituted in the 11-position to give benzodiazepin-6-ones | |
| CH391703A (en) | Process for the preparation of new carbostyril derivatives | |
| AT227259B (en) | Process for the preparation of new, 4-substituted 1, 2-diaryl-3, 5-dioxo-pyrazolidines | |
| AT243268B (en) | Process for the preparation of new benzoquinolizine derivatives | |
| DE1901167C3 (en) | Substituted indoles, processes for their preparation and pharmaceutical compositions | |
| AT351528B (en) | PROCESS FOR PRODUCING NEW INDAZOLE DERIVATIVES | |
| AT238193B (en) | Process for the production of new triazolidines | |
| DE2334973A1 (en) | NEW BIPHENYL DERIVATIVES | |
| AT230356B (en) | Process for the production of new benzoic acid derivatives | |
| AT235289B (en) | Process for the production of new triazolidines | |
| DE2856792A1 (en) | 1,2,3,4-TETRAHYDOPYDROPYRIDO SQUARE CLIP ON 4 ', 3' TO 4.5 SQUARE BRACKET TO THIAZOLO SQUARE BRACKET ON 3.2-ANGLE BRACKET FOR BENZIMIDAZOLE CONNECTIONS | |
| DE1249285B (en) | Process for the production of therapeutically effective seeds 1,2 diaryl-4-alkvl 3,5 dioxo pyrazohdmen |